The purpose of this study is to compare the new formulation of Tobradex to the current approved formulation
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Anterior chamber inflammation
Aqueous cells and flare
ocular pain
physician's impression of infection
frequency of treatment failures
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.